Insulet (PODD) Non Operating Interest Expenses (2010 - 2026)
Insulet's (PODD) quarterly Non Operating Interest Expenses came in at $13.5 million in Q2 2026, down 31.12% on a YoY basis from $19.6 million in Q2 2025, and down 8.16% quarter-over-quarter from $14.7 million in Q1 2026.
Analysis
Insulet (PODD) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Non Operating Interest Expenses for 15 consecutive years, with $13.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 31.12% year-over-year to $13.5 million; the trailing twelve-month figure through Jun 2026 stood at $58.7 million (up 17.87% YoY), and the FY2025 full-year result was $59.4 million, up 39.11% from the prior year.
- Non Operating Interest Expenses fell to $13.5 million in Q2 2026 per PODD's latest filing, from $14.7 million in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $19.6 million in Q2 2025 and bottomed at $6.7 million in Q4 2023.
- Historically, Non Operating Interest Expenses has averaged $11.5 million across 5 years, with a median of $10.5 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Non Operating Interest Expenses soared 78.18% in 2025, then tumbled 31.12% in 2026.
- Over 5 years, Non Operating Interest Expenses stood at $8.7 million in 2022, then dropped by 22.99% to $6.7 million in 2023, then grew by 28.36% to $8.6 million in 2024, then jumped by 73.26% to $14.9 million in 2025, then declined by 9.4% to $13.5 million in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $13.5 million, $14.7 million, and $14.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 127.32 Bn | 122.10 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 103.97 Bn | 100.50 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 63.66 Bn | 63.12 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.00 Bn | 31.54 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.04 Bn | 30.09 Bn | 830.00 Mn | - |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Insulet | 9.33 Bn | 8.80 Bn | 562.60 Mn | 13.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.50 Mn |
| Mar 31, 2026 | 14.70 Mn |
| Dec 31, 2025 | 14.90 Mn |
| Sep 30, 2025 | 15.60 Mn |
| Jun 30, 2025 | 19.60 Mn |
| Mar 31, 2025 | 9.20 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Sep 30, 2024 | 12.40 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Mar 31, 2024 | 10.70 Mn |
| Dec 31, 2023 | 6.70 Mn |
| Sep 30, 2023 | 10.40 Mn |
| Jun 30, 2023 | 9.70 Mn |
| Mar 31, 2023 | 9.40 Mn |
| Dec 31, 2022 | 8.70 Mn |
| Sep 30, 2022 | 9.20 Mn |
| Dec 31, 2019 | 10.97 Mn |
| Sep 30, 2019 | 9.37 Mn |
| Jun 30, 2019 | 7.64 Mn |
| Mar 31, 2019 | 6.62 Mn |